Literature DB >> 23298388

Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia.

Alice Bertero1, Adriano Boni, Mauro Gemmi, Mariacristina Gagliardi, Angelo Bifone, Giuseppe Bardi.   

Abstract

Dendrimers are branched polymers with spherical morphology. Their tuneable chemistry and surface modification make them valuable nanomaterials for biomedical applications. In view of possible dendrimer uses as brain-aimed nanocarriers, the authors studied amine- and lipid-functionalised (G4) polyamidoamine (PAMAM) biocompatibility with cell population forming the blood-brain barrier (BBB). Both amine-PAMAM and lipid-PAMAM dendrimers were able to enter endothelial and primary neural cells. However, only amine-PAMAM damaged cell membranes in a dose-dependent manner. Transmission electron microscopy evidenced the ability of dendrimers to precipitate salts and serum components present in culture medium that slightly increased toxicity of the amine-PAMAM. Amine- and lipid-PAMAM were both able to cross the BBB and differently induced CD11b and CCR2 overexpression on primary CX3CR1-GFP murine microglia in vitro. These data emphasise the role of dendrimer surface functionalisation in toxicity and neural immune cell activation, raising concerns about possible neuroinflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23298388     DOI: 10.3109/17435390.2013.765054

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  9 in total

1.  Epidermal growth factor receptor-targeted poly(amidoamine)-based dendrimer complexed oncolytic adenovirus: is it safe totally?

Authors:  Min Huang; Chun-Sheng Yang; Yong Xin; Guan Jiang
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

Review 2.  Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

Authors:  Xiang Li; Abid Naeem; Shanghua Xiao; Lei Hu; Jing Zhang; Qin Zheng
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

Review 3.  Drug delivery carriers with therapeutic functions.

Authors:  Shuting S Cai; Tianyu Li; Tolulope Akinade; Yuefei Zhu; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2021-07-21       Impact factor: 17.873

Review 4.  Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.

Authors:  Pratap C Naha; Sourav P Mukherjee; Hugh J Byrne
Journal:  Int J Environ Res Public Health       Date:  2018-02-14       Impact factor: 3.390

5.  PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice.

Authors:  Bhairavi Srinageshwar; Sarah Peruzzaro; Melissa Andrews; Kayla Johnson; Allison Hietpas; Brittany Clark; Crystal McGuire; Eric Petersen; Jordyn Kippe; Andrew Stewart; Olivia Lossia; Abeer Al-Gharaibeh; Aaron Antcliff; Rebecca Culver; Douglas Swanson; Gary Dunbar; Ajit Sharma; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2017-03-14       Impact factor: 5.923

Review 6.  New Advances in General Biomedical Applications of PAMAM Dendrimers.

Authors:  Renan Vinicius de Araújo; Soraya da Silva Santos; Elizabeth Igne Ferreira; Jeanine Giarolla
Journal:  Molecules       Date:  2018-11-02       Impact factor: 4.411

Review 7.  Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma.

Authors:  Kunzhe Wu; Beibei Yu; Di Li; Yangyang Tian; Yan Liu; Jinlan Jiang
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

8.  Detection of fluorescent nanoparticle interactions with primary immune cell subpopulations by flow cytometry.

Authors:  Olimpia Gamucci; Alice Bertero; Maria Ada Malvindi; Stefania Sabella; Pier Paolo Pompa; Barbara Mazzolai; Giuseppe Bardi
Journal:  J Vis Exp       Date:  2014-03-28       Impact factor: 1.355

Review 9.  Metallic Nanoparticles: General Research Approaches to Immunological Characterization.

Authors:  Francesca Gatto; Giuseppe Bardi
Journal:  Nanomaterials (Basel)       Date:  2018-09-22       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.